Latest Financials News

Starpharma reports encouraging FDA feedback on its DEP® SN38 candidate for ovarian cancer and prepares for product launches in Saudi Arabia and UAE, supported by a solid $20.3 million cash position.

Austral Resources Australia Ltd reports steady operational progress and promising resource developments in its December 2024 quarter, while navigating an ongoing recapitalisation and leadership transition.

Unico Silver has completed its acquisition of the Joaquin silver district and launched a fully funded 50,000m drill program, revealing exceptional high-grade mineralisation across multiple prospects in Santa Cruz, Argentina.

NoviqTech has entered a strategic partnership with Evercity to integrate their platforms and expand blockchain-enabled carbon market solutions, targeting emerging markets like East Africa.

ReNerve Limited has reported a remarkable 260% increase in quarterly sales following its successful IPO, alongside strategic distribution deals in Hong Kong and the Middle East. The company is poised for further growth with upcoming clinical data and product developments.

PhosCo has achieved critical milestones with the approval of its Gassaat Phosphate Project and a strategic MoU with the Tunisian Government and EBRD, setting the stage for a major drilling campaign and positioning itself as a future global fertilizer supplier.

Jupiter Energy Limited reported a net operating cash inflow of $776,000 for the December 2024 quarter, maintaining a solid cash position despite heavy exploration expenditures.

Jupiter Energy Limited reported steady oil sales revenue of approximately US$1.76 million for Q4 2024, driven entirely by domestic channels, alongside commissioning a key gas utilisation project and launching a $4 million capital raise.

Boss Energy has declared commercial production effective January 1, 2025, reporting strong quarterly uranium output growth and a robust financial position. The company remains on track to deliver 850,000 pounds of U3O8 in FY2025 amid ongoing ramp-up and expansion initiatives.

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.

Skylark Minerals has reshaped its leadership team with seasoned gold industry veterans and agreed to divest its Citronen Zn-Pb Project, positioning the company for renewed growth and exploration success.

Hammer Metals Limited reports steady progress in its December 2024 quarter with multiple drilling programs underway across its Mount Isa copper-gold projects, while assay results from recent campaigns are eagerly awaited.